Medical Care
Global Covid-19 Rapid Diagnostic Test Market Research Report 2025
- Jul 08, 25
- ID: 348225
- Pages: 82
- Figures: 90
- Views: 2
The global market for Covid-19 Rapid Diagnostic Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Rapid Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Rapid Diagnostic Test.
The Covid-19 Rapid Diagnostic Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Rapid Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Rapid Diagnostic Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
BD
Ador Diagnostics (BATM)
bioMérieux
Hardy Diagnostics
Applied BioCode
Biocartis SA
Cellmid
Akonni Biosystems
Alveo Technologies
Bio-Rad
Cepheid
Diasorin
Cue Health
Curetis
Segment by Type
Immunoassay
Genomic and WGS
rRT-PCR
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Rapid Diagnostic Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Covid-19 Rapid Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Rapid Diagnostic Test.
The Covid-19 Rapid Diagnostic Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Covid-19 Rapid Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Rapid Diagnostic Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
BD
Ador Diagnostics (BATM)
bioMérieux
Hardy Diagnostics
Applied BioCode
Biocartis SA
Cellmid
Akonni Biosystems
Alveo Technologies
Bio-Rad
Cepheid
Diasorin
Cue Health
Curetis
Segment by Type
Immunoassay
Genomic and WGS
rRT-PCR
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Covid-19 Rapid Diagnostic Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassay
1.2.3 Genomic and WGS
1.2.4 rRT-PCR
1.3 Market by Application
1.3.1 Global Covid-19 Rapid Diagnostic Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Rapid Diagnostic Test Market Perspective (2020-2031)
2.2 Global Covid-19 Rapid Diagnostic Test Growth Trends by Region
2.2.1 Global Covid-19 Rapid Diagnostic Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Covid-19 Rapid Diagnostic Test Historic Market Size by Region (2020-2025)
2.2.3 Covid-19 Rapid Diagnostic Test Forecasted Market Size by Region (2026-2031)
2.3 Covid-19 Rapid Diagnostic Test Market Dynamics
2.3.1 Covid-19 Rapid Diagnostic Test Industry Trends
2.3.2 Covid-19 Rapid Diagnostic Test Market Drivers
2.3.3 Covid-19 Rapid Diagnostic Test Market Challenges
2.3.4 Covid-19 Rapid Diagnostic Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Rapid Diagnostic Test Players by Revenue
3.1.1 Global Top Covid-19 Rapid Diagnostic Test Players by Revenue (2020-2025)
3.1.2 Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Players (2020-2025)
3.2 Global Covid-19 Rapid Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Covid-19 Rapid Diagnostic Test Revenue
3.4 Global Covid-19 Rapid Diagnostic Test Market Concentration Ratio
3.4.1 Global Covid-19 Rapid Diagnostic Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Rapid Diagnostic Test Revenue in 2024
3.5 Global Key Players of Covid-19 Rapid Diagnostic Test Head office and Area Served
3.6 Global Key Players of Covid-19 Rapid Diagnostic Test, Product and Application
3.7 Global Key Players of Covid-19 Rapid Diagnostic Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Rapid Diagnostic Test Breakdown Data by Type
4.1 Global Covid-19 Rapid Diagnostic Test Historic Market Size by Type (2020-2025)
4.2 Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Type (2026-2031)
5 Covid-19 Rapid Diagnostic Test Breakdown Data by Application
5.1 Global Covid-19 Rapid Diagnostic Test Historic Market Size by Application (2020-2025)
5.2 Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
6.2 North America Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
6.4 North America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
7.2 Europe Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
7.4 Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
8.2 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2020-2025)
8.4 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
9.2 Latin America Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
9.4 Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
10.2 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
10.4 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Covid-19 Rapid Diagnostic Test Introduction
11.1.4 Abbott Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.1.5 Abbott Diagnostics Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Covid-19 Rapid Diagnostic Test Introduction
11.2.4 BD Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.2.5 BD Recent Development
11.3 Ador Diagnostics (BATM)
11.3.1 Ador Diagnostics (BATM) Company Details
11.3.2 Ador Diagnostics (BATM) Business Overview
11.3.3 Ador Diagnostics (BATM) Covid-19 Rapid Diagnostic Test Introduction
11.3.4 Ador Diagnostics (BATM) Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.3.5 Ador Diagnostics (BATM) Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Covid-19 Rapid Diagnostic Test Introduction
11.4.4 bioMérieux Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.4.5 bioMérieux Recent Development
11.5 Hardy Diagnostics
11.5.1 Hardy Diagnostics Company Details
11.5.2 Hardy Diagnostics Business Overview
11.5.3 Hardy Diagnostics Covid-19 Rapid Diagnostic Test Introduction
11.5.4 Hardy Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.5.5 Hardy Diagnostics Recent Development
11.6 Applied BioCode
11.6.1 Applied BioCode Company Details
11.6.2 Applied BioCode Business Overview
11.6.3 Applied BioCode Covid-19 Rapid Diagnostic Test Introduction
11.6.4 Applied BioCode Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.6.5 Applied BioCode Recent Development
11.7 Biocartis SA
11.7.1 Biocartis SA Company Details
11.7.2 Biocartis SA Business Overview
11.7.3 Biocartis SA Covid-19 Rapid Diagnostic Test Introduction
11.7.4 Biocartis SA Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.7.5 Biocartis SA Recent Development
11.8 Cellmid
11.8.1 Cellmid Company Details
11.8.2 Cellmid Business Overview
11.8.3 Cellmid Covid-19 Rapid Diagnostic Test Introduction
11.8.4 Cellmid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.8.5 Cellmid Recent Development
11.9 Akonni Biosystems
11.9.1 Akonni Biosystems Company Details
11.9.2 Akonni Biosystems Business Overview
11.9.3 Akonni Biosystems Covid-19 Rapid Diagnostic Test Introduction
11.9.4 Akonni Biosystems Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.9.5 Akonni Biosystems Recent Development
11.10 Alveo Technologies
11.10.1 Alveo Technologies Company Details
11.10.2 Alveo Technologies Business Overview
11.10.3 Alveo Technologies Covid-19 Rapid Diagnostic Test Introduction
11.10.4 Alveo Technologies Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.10.5 Alveo Technologies Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Details
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad Covid-19 Rapid Diagnostic Test Introduction
11.11.4 Bio-Rad Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.11.5 Bio-Rad Recent Development
11.12 Cepheid
11.12.1 Cepheid Company Details
11.12.2 Cepheid Business Overview
11.12.3 Cepheid Covid-19 Rapid Diagnostic Test Introduction
11.12.4 Cepheid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.12.5 Cepheid Recent Development
11.13 Diasorin
11.13.1 Diasorin Company Details
11.13.2 Diasorin Business Overview
11.13.3 Diasorin Covid-19 Rapid Diagnostic Test Introduction
11.13.4 Diasorin Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.13.5 Diasorin Recent Development
11.14 Cue Health
11.14.1 Cue Health Company Details
11.14.2 Cue Health Business Overview
11.14.3 Cue Health Covid-19 Rapid Diagnostic Test Introduction
11.14.4 Cue Health Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.14.5 Cue Health Recent Development
11.15 Curetis
11.15.1 Curetis Company Details
11.15.2 Curetis Business Overview
11.15.3 Curetis Covid-19 Rapid Diagnostic Test Introduction
11.15.4 Curetis Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.15.5 Curetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassay
1.2.3 Genomic and WGS
1.2.4 rRT-PCR
1.3 Market by Application
1.3.1 Global Covid-19 Rapid Diagnostic Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Rapid Diagnostic Test Market Perspective (2020-2031)
2.2 Global Covid-19 Rapid Diagnostic Test Growth Trends by Region
2.2.1 Global Covid-19 Rapid Diagnostic Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Covid-19 Rapid Diagnostic Test Historic Market Size by Region (2020-2025)
2.2.3 Covid-19 Rapid Diagnostic Test Forecasted Market Size by Region (2026-2031)
2.3 Covid-19 Rapid Diagnostic Test Market Dynamics
2.3.1 Covid-19 Rapid Diagnostic Test Industry Trends
2.3.2 Covid-19 Rapid Diagnostic Test Market Drivers
2.3.3 Covid-19 Rapid Diagnostic Test Market Challenges
2.3.4 Covid-19 Rapid Diagnostic Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Rapid Diagnostic Test Players by Revenue
3.1.1 Global Top Covid-19 Rapid Diagnostic Test Players by Revenue (2020-2025)
3.1.2 Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Players (2020-2025)
3.2 Global Covid-19 Rapid Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Covid-19 Rapid Diagnostic Test Revenue
3.4 Global Covid-19 Rapid Diagnostic Test Market Concentration Ratio
3.4.1 Global Covid-19 Rapid Diagnostic Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Rapid Diagnostic Test Revenue in 2024
3.5 Global Key Players of Covid-19 Rapid Diagnostic Test Head office and Area Served
3.6 Global Key Players of Covid-19 Rapid Diagnostic Test, Product and Application
3.7 Global Key Players of Covid-19 Rapid Diagnostic Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Rapid Diagnostic Test Breakdown Data by Type
4.1 Global Covid-19 Rapid Diagnostic Test Historic Market Size by Type (2020-2025)
4.2 Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Type (2026-2031)
5 Covid-19 Rapid Diagnostic Test Breakdown Data by Application
5.1 Global Covid-19 Rapid Diagnostic Test Historic Market Size by Application (2020-2025)
5.2 Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
6.2 North America Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
6.4 North America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
7.2 Europe Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
7.4 Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
8.2 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2020-2025)
8.4 Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
9.2 Latin America Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
9.4 Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size (2020-2031)
10.2 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025)
10.4 Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Covid-19 Rapid Diagnostic Test Introduction
11.1.4 Abbott Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.1.5 Abbott Diagnostics Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Covid-19 Rapid Diagnostic Test Introduction
11.2.4 BD Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.2.5 BD Recent Development
11.3 Ador Diagnostics (BATM)
11.3.1 Ador Diagnostics (BATM) Company Details
11.3.2 Ador Diagnostics (BATM) Business Overview
11.3.3 Ador Diagnostics (BATM) Covid-19 Rapid Diagnostic Test Introduction
11.3.4 Ador Diagnostics (BATM) Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.3.5 Ador Diagnostics (BATM) Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Covid-19 Rapid Diagnostic Test Introduction
11.4.4 bioMérieux Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.4.5 bioMérieux Recent Development
11.5 Hardy Diagnostics
11.5.1 Hardy Diagnostics Company Details
11.5.2 Hardy Diagnostics Business Overview
11.5.3 Hardy Diagnostics Covid-19 Rapid Diagnostic Test Introduction
11.5.4 Hardy Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.5.5 Hardy Diagnostics Recent Development
11.6 Applied BioCode
11.6.1 Applied BioCode Company Details
11.6.2 Applied BioCode Business Overview
11.6.3 Applied BioCode Covid-19 Rapid Diagnostic Test Introduction
11.6.4 Applied BioCode Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.6.5 Applied BioCode Recent Development
11.7 Biocartis SA
11.7.1 Biocartis SA Company Details
11.7.2 Biocartis SA Business Overview
11.7.3 Biocartis SA Covid-19 Rapid Diagnostic Test Introduction
11.7.4 Biocartis SA Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.7.5 Biocartis SA Recent Development
11.8 Cellmid
11.8.1 Cellmid Company Details
11.8.2 Cellmid Business Overview
11.8.3 Cellmid Covid-19 Rapid Diagnostic Test Introduction
11.8.4 Cellmid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.8.5 Cellmid Recent Development
11.9 Akonni Biosystems
11.9.1 Akonni Biosystems Company Details
11.9.2 Akonni Biosystems Business Overview
11.9.3 Akonni Biosystems Covid-19 Rapid Diagnostic Test Introduction
11.9.4 Akonni Biosystems Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.9.5 Akonni Biosystems Recent Development
11.10 Alveo Technologies
11.10.1 Alveo Technologies Company Details
11.10.2 Alveo Technologies Business Overview
11.10.3 Alveo Technologies Covid-19 Rapid Diagnostic Test Introduction
11.10.4 Alveo Technologies Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.10.5 Alveo Technologies Recent Development
11.11 Bio-Rad
11.11.1 Bio-Rad Company Details
11.11.2 Bio-Rad Business Overview
11.11.3 Bio-Rad Covid-19 Rapid Diagnostic Test Introduction
11.11.4 Bio-Rad Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.11.5 Bio-Rad Recent Development
11.12 Cepheid
11.12.1 Cepheid Company Details
11.12.2 Cepheid Business Overview
11.12.3 Cepheid Covid-19 Rapid Diagnostic Test Introduction
11.12.4 Cepheid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.12.5 Cepheid Recent Development
11.13 Diasorin
11.13.1 Diasorin Company Details
11.13.2 Diasorin Business Overview
11.13.3 Diasorin Covid-19 Rapid Diagnostic Test Introduction
11.13.4 Diasorin Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.13.5 Diasorin Recent Development
11.14 Cue Health
11.14.1 Cue Health Company Details
11.14.2 Cue Health Business Overview
11.14.3 Cue Health Covid-19 Rapid Diagnostic Test Introduction
11.14.4 Cue Health Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.14.5 Cue Health Recent Development
11.15 Curetis
11.15.1 Curetis Company Details
11.15.2 Curetis Business Overview
11.15.3 Curetis Covid-19 Rapid Diagnostic Test Introduction
11.15.4 Curetis Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025)
11.15.5 Curetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoassay
Table 3. Key Players of Genomic and WGS
Table 4. Key Players of rRT-PCR
Table 5. Global Covid-19 Rapid Diagnostic Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Covid-19 Rapid Diagnostic Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Covid-19 Rapid Diagnostic Test Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Covid-19 Rapid Diagnostic Test Market Share by Region (2020-2025)
Table 9. Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Covid-19 Rapid Diagnostic Test Market Share by Region (2026-2031)
Table 11. Covid-19 Rapid Diagnostic Test Market Trends
Table 12. Covid-19 Rapid Diagnostic Test Market Drivers
Table 13. Covid-19 Rapid Diagnostic Test Market Challenges
Table 14. Covid-19 Rapid Diagnostic Test Market Restraints
Table 15. Global Covid-19 Rapid Diagnostic Test Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Covid-19 Rapid Diagnostic Test Market Share by Players (2020-2025)
Table 17. Global Top Covid-19 Rapid Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Diagnostic Test as of 2024)
Table 18. Ranking of Global Top Covid-19 Rapid Diagnostic Test Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Covid-19 Rapid Diagnostic Test Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Covid-19 Rapid Diagnostic Test, Headquarters and Area Served
Table 21. Global Key Players of Covid-19 Rapid Diagnostic Test, Product and Application
Table 22. Global Key Players of Covid-19 Rapid Diagnostic Test, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Covid-19 Rapid Diagnostic Test Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Type (2020-2025)
Table 26. Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Type (2026-2031)
Table 28. Global Covid-19 Rapid Diagnostic Test Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Application (2020-2025)
Table 30. Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Application (2026-2031)
Table 32. North America Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Diagnostics Company Details
Table 48. Abbott Diagnostics Business Overview
Table 49. Abbott Diagnostics Covid-19 Rapid Diagnostic Test Product
Table 50. Abbott Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 51. Abbott Diagnostics Recent Development
Table 52. BD Company Details
Table 53. BD Business Overview
Table 54. BD Covid-19 Rapid Diagnostic Test Product
Table 55. BD Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 56. BD Recent Development
Table 57. Ador Diagnostics (BATM) Company Details
Table 58. Ador Diagnostics (BATM) Business Overview
Table 59. Ador Diagnostics (BATM) Covid-19 Rapid Diagnostic Test Product
Table 60. Ador Diagnostics (BATM) Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 61. Ador Diagnostics (BATM) Recent Development
Table 62. bioMérieux Company Details
Table 63. bioMérieux Business Overview
Table 64. bioMérieux Covid-19 Rapid Diagnostic Test Product
Table 65. bioMérieux Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Hardy Diagnostics Company Details
Table 68. Hardy Diagnostics Business Overview
Table 69. Hardy Diagnostics Covid-19 Rapid Diagnostic Test Product
Table 70. Hardy Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 71. Hardy Diagnostics Recent Development
Table 72. Applied BioCode Company Details
Table 73. Applied BioCode Business Overview
Table 74. Applied BioCode Covid-19 Rapid Diagnostic Test Product
Table 75. Applied BioCode Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 76. Applied BioCode Recent Development
Table 77. Biocartis SA Company Details
Table 78. Biocartis SA Business Overview
Table 79. Biocartis SA Covid-19 Rapid Diagnostic Test Product
Table 80. Biocartis SA Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 81. Biocartis SA Recent Development
Table 82. Cellmid Company Details
Table 83. Cellmid Business Overview
Table 84. Cellmid Covid-19 Rapid Diagnostic Test Product
Table 85. Cellmid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 86. Cellmid Recent Development
Table 87. Akonni Biosystems Company Details
Table 88. Akonni Biosystems Business Overview
Table 89. Akonni Biosystems Covid-19 Rapid Diagnostic Test Product
Table 90. Akonni Biosystems Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 91. Akonni Biosystems Recent Development
Table 92. Alveo Technologies Company Details
Table 93. Alveo Technologies Business Overview
Table 94. Alveo Technologies Covid-19 Rapid Diagnostic Test Product
Table 95. Alveo Technologies Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 96. Alveo Technologies Recent Development
Table 97. Bio-Rad Company Details
Table 98. Bio-Rad Business Overview
Table 99. Bio-Rad Covid-19 Rapid Diagnostic Test Product
Table 100. Bio-Rad Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 101. Bio-Rad Recent Development
Table 102. Cepheid Company Details
Table 103. Cepheid Business Overview
Table 104. Cepheid Covid-19 Rapid Diagnostic Test Product
Table 105. Cepheid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 106. Cepheid Recent Development
Table 107. Diasorin Company Details
Table 108. Diasorin Business Overview
Table 109. Diasorin Covid-19 Rapid Diagnostic Test Product
Table 110. Diasorin Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 111. Diasorin Recent Development
Table 112. Cue Health Company Details
Table 113. Cue Health Business Overview
Table 114. Cue Health Covid-19 Rapid Diagnostic Test Product
Table 115. Cue Health Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 116. Cue Health Recent Development
Table 117. Curetis Company Details
Table 118. Curetis Business Overview
Table 119. Curetis Covid-19 Rapid Diagnostic Test Product
Table 120. Curetis Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 121. Curetis Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Covid-19 Rapid Diagnostic Test Picture
Figure 2. Global Covid-19 Rapid Diagnostic Test Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Covid-19 Rapid Diagnostic Test Market Share by Type: 2024 VS 2031
Figure 4. Immunoassay Features
Figure 5. Genomic and WGS Features
Figure 6. rRT-PCR Features
Figure 7. Global Covid-19 Rapid Diagnostic Test Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Covid-19 Rapid Diagnostic Test Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Covid-19 Rapid Diagnostic Test Report Years Considered
Figure 12. Global Covid-19 Rapid Diagnostic Test Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Covid-19 Rapid Diagnostic Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Covid-19 Rapid Diagnostic Test Market Share by Region: 2024 VS 2031
Figure 15. Global Covid-19 Rapid Diagnostic Test Market Share by Players in 2024
Figure 16. Global Top Covid-19 Rapid Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Diagnostic Test as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Covid-19 Rapid Diagnostic Test Revenue in 2024
Figure 18. North America Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 20. United States Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 24. Germany Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Share by Region (2020-2031)
Figure 32. China Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 40. Mexico Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 44. Turkey Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Diagnostics Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 48. BD Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 49. Ador Diagnostics (BATM) Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 50. bioMérieux Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 51. Hardy Diagnostics Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 52. Applied BioCode Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 53. Biocartis SA Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 54. Cellmid Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 55. Akonni Biosystems Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 56. Alveo Technologies Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 57. Bio-Rad Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 58. Cepheid Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 59. Diasorin Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 60. Cue Health Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 61. Curetis Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoassay
Table 3. Key Players of Genomic and WGS
Table 4. Key Players of rRT-PCR
Table 5. Global Covid-19 Rapid Diagnostic Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Covid-19 Rapid Diagnostic Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Covid-19 Rapid Diagnostic Test Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Covid-19 Rapid Diagnostic Test Market Share by Region (2020-2025)
Table 9. Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Covid-19 Rapid Diagnostic Test Market Share by Region (2026-2031)
Table 11. Covid-19 Rapid Diagnostic Test Market Trends
Table 12. Covid-19 Rapid Diagnostic Test Market Drivers
Table 13. Covid-19 Rapid Diagnostic Test Market Challenges
Table 14. Covid-19 Rapid Diagnostic Test Market Restraints
Table 15. Global Covid-19 Rapid Diagnostic Test Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Covid-19 Rapid Diagnostic Test Market Share by Players (2020-2025)
Table 17. Global Top Covid-19 Rapid Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Diagnostic Test as of 2024)
Table 18. Ranking of Global Top Covid-19 Rapid Diagnostic Test Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Covid-19 Rapid Diagnostic Test Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Covid-19 Rapid Diagnostic Test, Headquarters and Area Served
Table 21. Global Key Players of Covid-19 Rapid Diagnostic Test, Product and Application
Table 22. Global Key Players of Covid-19 Rapid Diagnostic Test, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Covid-19 Rapid Diagnostic Test Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Type (2020-2025)
Table 26. Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Type (2026-2031)
Table 28. Global Covid-19 Rapid Diagnostic Test Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Application (2020-2025)
Table 30. Global Covid-19 Rapid Diagnostic Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Covid-19 Rapid Diagnostic Test Revenue Market Share by Application (2026-2031)
Table 32. North America Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Diagnostics Company Details
Table 48. Abbott Diagnostics Business Overview
Table 49. Abbott Diagnostics Covid-19 Rapid Diagnostic Test Product
Table 50. Abbott Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 51. Abbott Diagnostics Recent Development
Table 52. BD Company Details
Table 53. BD Business Overview
Table 54. BD Covid-19 Rapid Diagnostic Test Product
Table 55. BD Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 56. BD Recent Development
Table 57. Ador Diagnostics (BATM) Company Details
Table 58. Ador Diagnostics (BATM) Business Overview
Table 59. Ador Diagnostics (BATM) Covid-19 Rapid Diagnostic Test Product
Table 60. Ador Diagnostics (BATM) Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 61. Ador Diagnostics (BATM) Recent Development
Table 62. bioMérieux Company Details
Table 63. bioMérieux Business Overview
Table 64. bioMérieux Covid-19 Rapid Diagnostic Test Product
Table 65. bioMérieux Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Hardy Diagnostics Company Details
Table 68. Hardy Diagnostics Business Overview
Table 69. Hardy Diagnostics Covid-19 Rapid Diagnostic Test Product
Table 70. Hardy Diagnostics Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 71. Hardy Diagnostics Recent Development
Table 72. Applied BioCode Company Details
Table 73. Applied BioCode Business Overview
Table 74. Applied BioCode Covid-19 Rapid Diagnostic Test Product
Table 75. Applied BioCode Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 76. Applied BioCode Recent Development
Table 77. Biocartis SA Company Details
Table 78. Biocartis SA Business Overview
Table 79. Biocartis SA Covid-19 Rapid Diagnostic Test Product
Table 80. Biocartis SA Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 81. Biocartis SA Recent Development
Table 82. Cellmid Company Details
Table 83. Cellmid Business Overview
Table 84. Cellmid Covid-19 Rapid Diagnostic Test Product
Table 85. Cellmid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 86. Cellmid Recent Development
Table 87. Akonni Biosystems Company Details
Table 88. Akonni Biosystems Business Overview
Table 89. Akonni Biosystems Covid-19 Rapid Diagnostic Test Product
Table 90. Akonni Biosystems Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 91. Akonni Biosystems Recent Development
Table 92. Alveo Technologies Company Details
Table 93. Alveo Technologies Business Overview
Table 94. Alveo Technologies Covid-19 Rapid Diagnostic Test Product
Table 95. Alveo Technologies Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 96. Alveo Technologies Recent Development
Table 97. Bio-Rad Company Details
Table 98. Bio-Rad Business Overview
Table 99. Bio-Rad Covid-19 Rapid Diagnostic Test Product
Table 100. Bio-Rad Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 101. Bio-Rad Recent Development
Table 102. Cepheid Company Details
Table 103. Cepheid Business Overview
Table 104. Cepheid Covid-19 Rapid Diagnostic Test Product
Table 105. Cepheid Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 106. Cepheid Recent Development
Table 107. Diasorin Company Details
Table 108. Diasorin Business Overview
Table 109. Diasorin Covid-19 Rapid Diagnostic Test Product
Table 110. Diasorin Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 111. Diasorin Recent Development
Table 112. Cue Health Company Details
Table 113. Cue Health Business Overview
Table 114. Cue Health Covid-19 Rapid Diagnostic Test Product
Table 115. Cue Health Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 116. Cue Health Recent Development
Table 117. Curetis Company Details
Table 118. Curetis Business Overview
Table 119. Curetis Covid-19 Rapid Diagnostic Test Product
Table 120. Curetis Revenue in Covid-19 Rapid Diagnostic Test Business (2020-2025) & (US$ Million)
Table 121. Curetis Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Covid-19 Rapid Diagnostic Test Picture
Figure 2. Global Covid-19 Rapid Diagnostic Test Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Covid-19 Rapid Diagnostic Test Market Share by Type: 2024 VS 2031
Figure 4. Immunoassay Features
Figure 5. Genomic and WGS Features
Figure 6. rRT-PCR Features
Figure 7. Global Covid-19 Rapid Diagnostic Test Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Covid-19 Rapid Diagnostic Test Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Covid-19 Rapid Diagnostic Test Report Years Considered
Figure 12. Global Covid-19 Rapid Diagnostic Test Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Covid-19 Rapid Diagnostic Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Covid-19 Rapid Diagnostic Test Market Share by Region: 2024 VS 2031
Figure 15. Global Covid-19 Rapid Diagnostic Test Market Share by Players in 2024
Figure 16. Global Top Covid-19 Rapid Diagnostic Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Rapid Diagnostic Test as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Covid-19 Rapid Diagnostic Test Revenue in 2024
Figure 18. North America Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 20. United States Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 24. Germany Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Covid-19 Rapid Diagnostic Test Market Share by Region (2020-2031)
Figure 32. China Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 40. Mexico Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Covid-19 Rapid Diagnostic Test Market Share by Country (2020-2031)
Figure 44. Turkey Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Covid-19 Rapid Diagnostic Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Diagnostics Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 48. BD Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 49. Ador Diagnostics (BATM) Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 50. bioMérieux Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 51. Hardy Diagnostics Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 52. Applied BioCode Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 53. Biocartis SA Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 54. Cellmid Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 55. Akonni Biosystems Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 56. Alveo Technologies Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 57. Bio-Rad Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 58. Cepheid Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 59. Diasorin Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 60. Cue Health Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 61. Curetis Revenue Growth Rate in Covid-19 Rapid Diagnostic Test Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Advanced Enteric Capsules Market Research Report 2025
Jul 08, 25
Global Outdoor Structures and Chairs Market Research Report 2025
Jul 08, 25
Global Herbs Ingredients Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232